KLK3 and neoplasm: As shown in Fig. 6A, when compared to the control group, the tumor progression rate is significantly lower in the group of mice treated with the prodrug 2, which is coherent with the observed decrease in circulating PSA levels being a direct marker of LNCaP xenograft size43 (Fig. 6B).